Annual Accounts Receivable
$799.70 K
-$2.07 M-72.12%
December 31, 2023
Summary
- As of February 23, 2025, BGLC annual accounts receivable is $799.70 thousand, with the most recent change of -$2.07 million (-72.12%) on December 31, 2023.
- During the last 3 years, BGLC annual accounts receivable has fallen by -$3.20 million (-79.99%).
- BGLC annual accounts receivable is now -79.99% below its all-time high of $4.00 million, reached on December 1, 2020.
Performance
BGLC Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$1.43 M
+$437.30 K+44.26%
September 30, 2024
Summary
- As of February 23, 2025, BGLC quarterly accounts receivable is $1.43 million, with the most recent change of +$437.30 thousand (+44.26%) on September 30, 2024.
- Over the past year, BGLC quarterly accounts receivable has stayed the same.
- BGLC quarterly accounts receivable is now -65.99% below its all-time high of $4.19 million, reached on September 1, 2021.
Performance
BGLC Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
BGLC Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -72.1% | 0.0% |
| 3 y3 years | -80.0% | -43.6% |
| 5 y5 years | - | -43.6% |
BGLC Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -76.2% | at low | -57.5% | +78.2% |
| 5 y | 5-year | -80.0% | -100.0% | -66.0% | -100.0% |
| alltime | all time | -80.0% | -100.0% | -66.0% | -100.0% |
BioNexus Gene Lab Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.43 M(+44.3%) |
| Jun 2024 | - | $988.00 K(+17.7%) |
| Mar 2024 | - | $839.60 K(+5.0%) |
| Dec 2023 | $799.70 K(-72.1%) | $799.70 K(-11.2%) |
| Sep 2023 | - | $900.40 K(-59.0%) |
| Jun 2023 | - | $2.20 M(-13.2%) |
| Mar 2023 | - | $2.53 M(-11.8%) |
| Dec 2022 | $2.87 M | $2.87 M(+5.2%) |
| Sep 2022 | - | $2.73 M(-3.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $2.83 M(-6.8%) |
| Mar 2022 | - | $3.03 M(-9.6%) |
| Dec 2021 | $3.36 M(-16.0%) | - |
| Dec 2021 | - | $3.36 M(-19.9%) |
| Sep 2021 | - | $4.19 M(+8.0%) |
| Jun 2021 | - | $3.88 M(+8.0%) |
| Mar 2021 | - | $3.59 M(-10.1%) |
| Dec 2020 | $4.00 M(>+9900.0%) | $4.00 M(>+9900.0%) |
| Dec 2019 | $0.00 | $0.00 |
FAQ
- What is BioNexus Gene Lab annual accounts receivable?
- What is the all time high annual accounts receivable for BioNexus Gene Lab?
- What is BioNexus Gene Lab annual accounts receivable year-on-year change?
- What is BioNexus Gene Lab quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for BioNexus Gene Lab?
- What is BioNexus Gene Lab quarterly accounts receivable year-on-year change?
What is BioNexus Gene Lab annual accounts receivable?
The current annual accounts receivable of BGLC is $799.70 K
What is the all time high annual accounts receivable for BioNexus Gene Lab?
BioNexus Gene Lab all-time high annual accounts receivable is $4.00 M
What is BioNexus Gene Lab annual accounts receivable year-on-year change?
Over the past year, BGLC annual accounts receivable has changed by -$2.07 M (-72.12%)
What is BioNexus Gene Lab quarterly accounts receivable?
The current quarterly accounts receivable of BGLC is $1.43 M
What is the all time high quarterly accounts receivable for BioNexus Gene Lab?
BioNexus Gene Lab all-time high quarterly accounts receivable is $4.19 M
What is BioNexus Gene Lab quarterly accounts receivable year-on-year change?
Over the past year, BGLC quarterly accounts receivable has changed by $0.00 (0.00%)